{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05985291",
            "orgStudyIdInfo": {
                "id": "23-817"
            },
            "organization": {
                "fullName": "Aurora Health Care",
                "class": "OTHER"
            },
            "briefTitle": "BurstDR Stimulation for Painful Diabetic Neuropathy",
            "officialTitle": "BurstDRTM Spinal Cord Dorsal Column Stimulation for Painful Diabetic Neuropathy",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "burstdr-stimulation-for-painful-diabetic-neuropathy"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-03",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-10-03",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-06",
            "studyFirstSubmitQcDate": "2023-08-09",
            "studyFirstPostDateStruct": {
                "date": "2023-08-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-08-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-08-14",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mansoor Aman, MD",
                "investigatorTitle": "Director, Interventional Pain Medicine- Oshkosh & Fond du Lac",
                "investigatorAffiliation": "Aurora Health Care"
            },
            "leadSponsor": {
                "name": "Aurora Health Care",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study aims to demonstrate treatment outcomes of Painful Diabetic Neuropathy (PDN) patients treated with BurstDRTM Spinal Cord Dorsal Column Stimulator (SCS) along with conservative medical management per standard of care."
        },
        "conditionsModule": {
            "conditions": [
                "Painful Diabetic Neuropathy"
            ],
            "keywords": [
                "neurostimulation",
                "spinal cord stimulation",
                "burst stimulation"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "6 Months",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "PDN treated with SCS and CMM",
                    "description": "Painful diabetic neuropathy patients treated with burst stimulation along with conservative medical management as part of regular medical care.",
                    "interventionNames": [
                        "Combination Product: SCS in combination with CMM"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "SCS in combination with CMM",
                    "description": "Subjects receiving BurstDR spinal cord dorsal column stimulation in combination with conservative medical management for the treatment of painful diabetic neuropathy as part of regular medical care.",
                    "armGroupLabels": [
                        "PDN treated with SCS and CMM"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Average change from baseline to 3 months in treatment responder rates",
                    "description": "Responder is defined as a subject who has at least 50% reduction in lower limb pain from baseline as measured by a 10 cm Visual Analog Scale (VAS).",
                    "timeFrame": "3 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Average change from baseline to 6 months in treatment responder rates assessed by Visual Analog Scale (0-10 cm)",
                    "description": "0 no pain at all, 10 worse pain imaginable",
                    "timeFrame": "6 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Percentage of patients with change from baseline in sensory neurological assessment at 3 months",
                    "description": "Assessed by the healthcare provider.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Average change from baseline to 3 months in severity of neuropathic pain as measured by Neuropathic Pain 4 Questions (DN4) (0-10)",
                    "description": "score of 4 or greater indicates neuropathic pain",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Average change from baseline in CGM metrics from AGP report at 3 months",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Average change from baseline in health-related quality of life at 3 months as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS-29)",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Average change in proportion of remitters (remission is defined as having a lower limb pain Visual Analog Score score \u2264 2.5 cm) at 6 months",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Average change in health-related quality of life as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS-29) at 6 months",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Average change from baseline to 3 months in opioid dosage measured in total morphine milligram equivalents (MME)",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Proportion of participants with clinically meaningful improvement on sensory neurological examination as determined by the investigator at 6 months compared to baseline.",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Average change from baseline to 6 months in opioid dosage measured in total MME",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Average change from baseline to 6 months in severity of neuropathic pain as measured by DN4",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Difference in average percentage change from baseline in CGM metrics from AGP report at 6 months",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Assessment of subject outcomes satisfaction as measured through Patient Global Impression of Change (PGIC) (1-7 where higher scores mean better outcome) at 3 months and 6 months.",
                    "timeFrame": "3 & 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of lower extremity Painful Diabetic Neuropathy (PDN) with symptoms for at least a year prior to signing the consent form\n* PDN refractory to FDA approved medications: duloxetine, pregabalin, tapentadol, and capscaicin\n* Lower limb pain intensity of 5 cm or more on a 10-cm visual analogue scale (VAS)\n* HbA1c \u226410%\n* BMI \\<45 kg/m2\n* Be 22 years of age or older at the time of enrollment\n* Be an appropriate candidate for the surgical procedures required in this study based on the clinical judgment of the implanting physician\n* Be capable of subjective evaluation, able to read and understand English-written questionnaires, and able to read, understand and sign the written informed consent in English\n* Be willing and capable of giving informed consent\n* Be willing and able to comply with study-related requirements, procedures, and scheduled visits\n* Have adequate cognitive ability to use a patient programmer and recharger as determined by the Investigator\n* Be on a stable analgesic regimen, as determined by the Investigator, for at least 30 days prior to assessing pain intensity, and be willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device\n* Have stable neurological status measured by motor, sensory and reflex function as determined by the investigator\n\nExclusion Criteria:\n\n* Current daily opioid dosage greater than 120 mg morphine equivalents\n* Have an average pain intensity of \u2265 3 out of 10 cm on the VAS in the upper extremities due to diabetic neuropathy at enrollment\n* Have a diagnosis of a lower limb mononeuropathy (e.g., causalgia and tibial or peroneal neuropathies), have had a lower limb amputation other than toes due to diabetes, or have large (\u22653 cm) and/or gangrenous ulcers of the lower limbs.\n* Have a current diagnosis of a progressive neurological disease such as multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, rapidly progressive arachnoiditis, brain or spinal cord tumor, central deafferentation syndrome,Complex Regional Pain Syndrome, acute herniating disc, severe spinal stenosis and brachial plexus injury, as determined by the Investigator\n* Have a current diagnosis or condition such as a coagulation disorder, bleeding diathesis, platelet dysfunction, low platelet count, severely diminished functional capacity due to underlying cardiac/pulmonary disease, symptomatic uncontrolled hypertension, progressive peripheral vascular disease or uncontrolled diabetes mellitus that presents excess risk for performing the procedure, as determined clinically by the Investigator\n* Have prior experience with SCS, dorsal root ganglion (DRG) stimulation, peripheral nerve field stimulation (PNfS), or peripheral nerve stimulation (PNS) for chronic intractable pain\n* Be benefitting from an interventional procedure and/or surgery to treat lower limb pain (Subjects should be enrolled at least 30 days from last benefit).\n* Have an existing intrathecal pain pump and/or another active implantable device such as a pacemaker\n* Have a condition currently requiring or likely to require the use of diathermy or MRI that is inconsistent with ProclaimTM system guidelines in the Physician's Manual\n* Have either a metastatic malignant neoplasm or untreated local malignant neoplasm\n* Have a life expectancy of less than one year\n* Have a local infection at the anticipated surgical entry site or an active systemic infection\n* Have within 6 months of enrollment a significant untreated addiction to dependency producing medications, alcohol or illicit drugs\n* Be concomitantly participating in another clinical study\n* Be involved in an injury claim under current litigation\n* Be a recipient of temporary Social Security Disability Insurance (SSDI) benefits due to chronic pain\n* Have a pending or approved worker's compensation claim\n* Have evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance with intervention and/or ability to evaluate treatment outcome, as determined by a psychologist in the last 12 months",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "This study will include patients older than 21 suffering from Painful Diabetic Neuropathy.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Merve Buluk Figueira, MS",
                    "role": "CONTACT",
                    "phone": "9204561551",
                    "email": "merve.figueira@aah.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mansoor Aman, MD",
                    "affiliation": "Aurora Healthcare",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Aurora Health Oshkosh",
                    "status": "RECRUITING",
                    "city": "Oshkosh",
                    "state": "Wisconsin",
                    "zip": "54914",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Merve Buluk Figueira, MS",
                            "role": "CONTACT",
                            "phone": "920-456-1551",
                            "email": "merve.figueira@aah.org"
                        },
                        {
                            "name": "Mansoor Aman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Vishal Patel, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Lauren Lyons, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02471,
                        "lon": -88.54261
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Data sharing with external institutions is not approved by the Aurora IRB."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003929",
                    "term": "Diabetic Neuropathies"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010523",
                    "term": "Peripheral Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7124",
                    "name": "Diabetic Neuropathies",
                    "asFound": "Diabetic Neuropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "asFound": "Painful",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13432",
                    "name": "Peripheral Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        }
    },
    "hasResults": false
}